Direct Evidence for the Presence of Human Milk Oligosaccharides in the Circulation of Breastfed Infants

Background It has been hypothesized that human milk oligosaccharides (HMOs) confer systemic health benefits to breastfed infants; however, plausible mechanisms for some effects, such as systemic immunomodulation, require HMOs to access the bloodstream of the developing infant. While small concentrations of HMOs have been detected in the urine of breastfed infants there are no published studies of these oligosaccharides accessing the plasma compartment of breastfed infants. Here we determined the relative fractions of several ingested HMOs in infant urine and plasma. Plasma from formula-fed infants was used as a control. Methods Using gas chromatography/mass spectrometry (GC/MS), liquid chromatography/mass spectrometry/tandem mass spectrometry (LC/MS/MS), and high performance liquid chromatography (HPLC), we analyzed the urine and plasma from 17 healthy formula-fed infants and 16 healthy breast-fed infants (and the milk from their mothers). Results Multiple HMOs were detected in the urine and plasma of breastfed infants, but not in formula-fed infants. Levels of 2′-fucosyllactose (2′FL), 3FL and lacto-N-neotetraose (LNnT) in both plasma (r = 0.98, p<0.001; r = 0.75, p = 0.002; r = 0.71, p = 0.004) and urine (r = 0.81, p<0.001; r = 0.56, p = 0.026; NS) correlated significantly with concentrations in the corresponding breast milk. The relative fractions of HMOs were low, 0.1% of milk levels for plasma and 4% of milk levels for urine. Within the breastfed cohort, there were significant differences between secretor and nonsecretor groups in levels of several fucosylated HMOs. Conclusion At least some ingested HMOs are absorbed intact into the circulation and excreted in the urine and their concentrations in these fluids correlate with levels of the corresponding mother's milk. While relative fractions of absorbed HMOs were low, these levels have been shown to have biological effects in vitro, and could explain some of the postulated benefits of human milk.

[1]  R. Geyer,et al.  13C-labeled oligosaccharides in breastfed infants' urine: individual-, structure- and time-dependent differences in the excretion. , 2014, Glycobiology.

[2]  Gwendolyn Radzanowski,et al.  Short‐chain milk oligosaccharide levels in human milk and infant plasma , 2013 .

[3]  John S. Strum,et al.  A quantitative and comprehensive method to analyze human milk oligosaccharide structures in the urine and feces of infants , 2013, Analytical and Bioanalytical Chemistry.

[4]  M. Heidtman,et al.  The principal fucosylated oligosaccharides of human milk exhibit prebiotic properties on cultured infant microbiota. , 2013, Glycobiology.

[5]  L. R. Ruhaak,et al.  Comprehensive profiles of human milk oligosaccharides yield highly sensitive and specific markers for determining secretor status in lactating mothers. , 2012, Journal of proteome research.

[6]  Kenji Yamamoto.  Biological Analysis of the Microbial Metabolism of Hetero-Oligosaccharides in Application to Glycotechnology , 2012, Bioscience, biotechnology, and biochemistry.

[7]  John S. Strum,et al.  Lacto-N-tetraose, fucosylation, and secretor status are highly variable in human milk oligosaccharides from women delivering preterm. , 2012, Journal of proteome research.

[8]  Lars Bode,et al.  Human milk oligosaccharides: every baby needs a sugar mama. , 2012, Glycobiology.

[9]  Rong-Fu Chen,et al.  Protection from Viral Infections by Human Milk Oligosaccharides: Direct Blockade and Indirect Modulation of Intestinal Ecology and Immune Reactions , 2012 .

[10]  P. Prieto.  Profiles of human milk oligosaccharides and production of some human milk oligosaccharides in transgenic animals. , 2012, Advances in nutrition.

[11]  G. Rabinovich,et al.  Glycobiology of immune responses , 2012, Annals of the New York Academy of Sciences.

[12]  L. Bode,et al.  Human milk oligosaccharides and their potential benefits for the breast-fed neonate. , 2012, Minerva pediatrica.

[13]  C. Kunz,et al.  Urinary excretion of in vivo 13C-labelled milk oligosaccharides in breastfed infants , 2011, British Journal of Nutrition.

[14]  A. Kraneveld,et al.  Glycan recognition at the interface of the intestinal immune system: target for immune modulation via dietary components. , 2011, European journal of pharmacology.

[15]  B. Fong,et al.  Quantification of bovine milk oligosaccharides using liquid chromatography-selected reaction monitoring-mass spectrometry. , 2011, Journal of agricultural and food chemistry.

[16]  M. Kitaoka,et al.  Physiology of Consumption of Human Milk Oligosaccharides by Infant Gut-associated Bifidobacteria* , 2011, The Journal of Biological Chemistry.

[17]  D. Barile,et al.  Bovine milk as a source of functional oligosaccharides for improving human health. , 2011, Advances in nutrition.

[18]  B. Stahl,et al.  Prebiotic oligosaccharides: In vitro evidence for gastrointestinal epithelial transfer and immunomodulatory properties , 2010, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[19]  S. Thurl,et al.  Variation of human milk oligosaccharides in relation to milk groups and lactational periods. , 2010, The British journal of nutrition.

[20]  Anne M. Evans,et al.  Organization of GC/MS and LC/MS metabolomics data into chemical libraries , 2010, J. Cheminformatics.

[21]  Osamu Okazaki,et al.  Ethylene Glycol Monomethyl Ether–Induced Toxicity Is Mediated through the Inhibition of Flavoprotein Dehydrogenase Enzyme Family , 2010, Toxicological sciences : an official journal of the Society of Toxicology.

[22]  A. Hofman,et al.  Prolonged and Exclusive Breastfeeding Reduces the Risk of Infectious Diseases in Infancy , 2010, Pediatrics.

[23]  Andrea Natali,et al.  α-Hydroxybutyrate Is an Early Biomarker of Insulin Resistance and Glucose Intolerance in a Nondiabetic Population , 2010, PloS one.

[24]  John W. Froehlich,et al.  Consumption of human milk oligosaccharides by gut-related microbes. , 2010, Journal of agricultural and food chemistry.

[25]  I. Penttila.  Milk-derived transforming growth factor-beta and the infant immune response. , 2010, The Journal of pediatrics.

[26]  C. Lebrilla,et al.  Mass spectrometric methods for analysis of oligosaccharides in human milk. , 2009, Nutrition reviews.

[27]  Corey D. DeHaven,et al.  Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems. , 2009, Analytical chemistry.

[28]  Tadashi Nakamura,et al.  Variation of major neutral oligosaccharides levels in human colostrum , 2008, European Journal of Clinical Nutrition.

[29]  C. Kunz,et al.  Oligosaccharides from human milk influence growth-related characteristics of intestinally transformed and non-transformed intestinal cells , 2008, British Journal of Nutrition.

[30]  C. Lebrilla,et al.  Glycoprofiling of bifidobacterial consumption of human milk oligosaccharides demonstrates strain specific, preferential consumption of small chain glycans secreted in early human lactation. , 2007, Journal of agricultural and food chemistry.

[31]  Martha Tamez,et al.  Efforts to emulate human milk oligosaccharides , 2007, British Journal of Nutrition.

[32]  A. Sacker,et al.  Breastfeeding and Hospitalization for Diarrheal and Respiratory Infection in the United Kingdom Millennium Cohort Study , 2007, Pediatrics.

[33]  T. Trikalinos,et al.  Breastfeeding and maternal and infant health outcomes in developed countries. , 2007, Evidence report/technology assessment.

[34]  M. Hertzog,et al.  Early consumption of human milk oligosaccharides is inversely related to subsequent risk of respiratory and enteric disease in infants. , 2006, Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine.

[35]  M. Musumeci,et al.  Immunomodulation of Fucosyl-Lactose and Lacto-N-Fucopentaose on Mononuclear Cells from Multiple Sclerosis and Healthy Subjects , 2006, International journal of biomedical science : IJBS.

[36]  C. Kunz,et al.  Incorporation of orally applied (13)C-galactose into milk lactose and oligosaccharides. , 2006, Glycobiology.

[37]  B. Berkhout,et al.  Lewis X component in human milk binds DC-SIGN and inhibits HIV-1 transfer to CD4+ T lymphocytes. , 2005, The Journal of clinical investigation.

[38]  J. Garssen,et al.  Galacto‐oligosaccharides and long‐chain fructo‐oligosaccharides as prebiotics in infant formulas: A review , 2005, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[39]  J. Garssen,et al.  Galacto-oligosaccharides and long-chain fructo-oligosaccharides as prebiotics in infant formulas: A review , 2005 .

[40]  Lars Bode,et al.  Inhibition of monocyte, lymphocyte, and neutrophil adhesion to endothelial cells by human milk oligosaccharides , 2004, Thrombosis and Haemostasis.

[41]  Nigel Klein,et al.  Human milk oligosaccharides reduce platelet‐neutrophil complex formation leading to a decrease in neutrophil β 2 integrin expression , 2004, Journal of leukocyte biology.

[42]  B. Stahl,et al.  Human Milk–Derived Oligosaccharides and Plant-Derived Oligosaccharides Stimulate Cytokine Production of Cord Blood T-Cells In Vitro , 2004, Pediatric Research.

[43]  E. Hodnett,et al.  Infant growth and health outcomes associated with 3 compared with 6 mo of exclusive breastfeeding. , 2003, The American journal of clinical nutrition.

[44]  H. Klenk,et al.  Natural and synthetic sialic acid‐containing inhibitors of influenza virus receptor binding , 2003, Reviews in medical virology.

[45]  B. Vohr,et al.  Human Milk Reduces Outpatient Upper Respiratory Symptoms in Premature Infants During Their First Year of Life , 2002, Journal of Perinatology.

[46]  C. Kunz,et al.  Investigations of the in Vitro Transport of Human Milk Oligosaccharides by a Caco-2 Monolayer Using a Novel High Performance Liquid Chromatography-Mass Spectrometry Technique* , 2001, The Journal of Biological Chemistry.

[47]  M. Altaye,et al.  Fucosylated human milk oligosaccharides vary between individuals and over the course of lactation. , 2001, Glycobiology.

[48]  W. T. Malone,et al.  Variability of human milk neutral oligosaccharides in a diverse population. , 2000, Journal of pediatric gastroenterology and nutrition.

[49]  H. Egge,et al.  Urinary excretion of lactose and oligosaccharides in preterm infants fed human milk or infant formula , 1996, Acta paediatrica.

[50]  S. Thurl,et al.  Quantification of individual oligosaccharide compounds from human milk using high-pH anion-exchange chromatography. , 1996, Analytical biochemistry.

[51]  S. Thurl,et al.  Variations of neutral oligosaccharides and lactose in human milk during the feeding , 1993, Zeitschrift fur Ernahrungswissenschaft.

[52]  P. Prieto.  In Vitro and Clinical Experiences with a Human Milk Oligosaccharide, Lacto-N-neoTetraose, and Fructooligosaccharides (Feature Articles: International Symposium on Non-digestible Carbohydrate(2)) , 2005 .

[53]  S. Martín-Sosa,et al.  Sialyloligosaccharides in human and bovine milk and in infant formulas: variations with the progression of lactation. , 2003, Journal of dairy science.

[54]  N Klein,et al.  Oligosaccharides in human milk: structural, functional, and metabolic aspects. , 2000, Annual review of nutrition.